results of clinical studies on food supplements company Neways REVENOL
"... We'll talk about antioxidants and their pharmacological effect, which is due to the ability to add free radicals and reduce the 'intensity of oxidative processes in the body. Remember that free radicals - are active bio-molecules, which damage the structure of cell membranes and cellular genetic apparatus. Today the market of food supplements, antioxidants are represented in large numbers. Apart all well-known as vitamins A, E and C, to this day are also very popular antioxidants of the new generation Pycnogenol (OPC), coenzyme Q10, melatonin, etc.. All the latest developments of science have been embrace by Neways, which now offers a full range of antioxidants. Revenol - super antioxidant policomponente - deserves special attention because it is composed of vitamins C, E, beta - carotene, pycnogenol (made from pine bark and grape seeds) and also the Ginkgo biloba and turmeric. Pycnogenol slows aging and the deterioration of cell membranes, increases the body's resistance to radiation and other environmental factors, normalizes the function of the cardiovascular and nervous system, strengthens the immune system and has an anti-cancer effect. Ginko biloba regulates the flow of blood in peripheral vessels and blood vessels of the brain. The main therapeutic effect of Ginkgo biloba is an increased blood flow in organs that have insufficient. Turmeric not only neutralizes free radicals, but also felt their training, increasing the antitoxic function of the liver. In recent years, scientists from different countries shared the view that one of the most important causes leading to cell damage - is the imbalance in the system of lipid peroxidation and antioxidant protection.
Prior research
Clinical trials on Revenol were conducted at the Research Center of Medical Radiology. I observed patients were found to have coronary heart diseases, various forms of arthritis, signs of atherosclerosis and trophic lesions of the extremities. The scheme according to which patients were Revenol was, during the first two weeks - 2 tablets 2 times daily, after 1 tablet 2 times daily for 1-2 months. With the result that almost all patients after treatment had improved state of health. Let me give an example more striking: a man of 42 years after falling in 1994 and broke two bones of the leg, then had two surgeries on the ankle. After these surgeries, every morning for 3-5 hours, the edema appeared in the area of \u200b\u200barticulation, and he was limping from the pain caused by the dysfunction of the joint. The ICU applied and intravenous injections of various corticosteroids had only a slight improvement. Instead, the patient had begun to take Revenol accordance with the scheme shown above after 2 weeks the pain and claudication had disappeared and the patient had begun to forget the trauma.
CONCLUSION: Our experience and results of clinical studies show that Revenol is not only one of the most powerful antioxidants of plant origin, but is also the protector and reinstatement of the connective tissue . So no analogues either among the variety of drugs in the pharmacopoeia or food supplements. As above we can | to recommend the use of Revenol in case of disease caused by imbalance of the functions of connective tissue. For example, in cases of diabetes mellitus, disease of the vascular wall, lesions of the articular cartilage and ligaments. Second search The theme of the study was: "The influence of Revenol during the treatment of myocardial infarction, signs of lipid peroxidation and of antioxidant protection. "The doctors looked at 19 patients aged between 45 and 70. The first group of patients taking Revenol according to the scheme standard of which we spoke earlier. The second group was the traditional treatment. The diagnosis was based on data of clinical trials on the results of laboratory and instrumental studies. The study showed that patients who had had myocardial infarction by antioxidant therapy, had obtained the best results in the analysis of a comparison with another group that was a traditional therapy. Analysis of the oxidation of free radicals in blood plasma showed a reduction in the level of activation of lipid peroxidation due to the applied therapy, anti-oxidant. This result is quite positive why the activation of lipid peroxidation is one of the ischemic damage causing myocardial infarction. CONCLUSION: Revenol can be recommended for antioxidant therapy against myocardial infarction. |
0 comments:
Post a Comment